369 related articles for article (PubMed ID: 32601948)
21. Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging.
Löwenthal D; Zeile M; Lim WY; Wybranski C; Fischbach F; Wieners G; Pech M; Kropf S; Ricke J; Dudeck O
Eur Radiol; 2011 Apr; 21(4):832-40. PubMed ID: 20886339
[TBL] [Abstract][Full Text] [Related]
22. Assessing liver function in patients with HBV-related HCC: a comparison of T₁ mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI.
Ding Y; Rao SX; Chen C; Li R; Zeng MS
Eur Radiol; 2015 May; 25(5):1392-8. PubMed ID: 25523455
[TBL] [Abstract][Full Text] [Related]
23. Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid.
Semaan S; Vietti Violi N; Lewis S; Chatterji M; Song C; Besa C; Babb JS; Fiel MI; Schwartz M; Thung S; Sirlin CB; Taouli B
Eur Radiol; 2020 Feb; 30(2):1020-1030. PubMed ID: 31673837
[TBL] [Abstract][Full Text] [Related]
24. Performance of adding hepatobiliary phase image in magnetic resonance imaging for detection of hepatocellular carcinoma: a meta-analysis.
Pan J; Li W; Gu L; Liu C; Zhang K; Hong G
Eur Radiol; 2022 Nov; 32(11):7883-7895. PubMed ID: 35579711
[TBL] [Abstract][Full Text] [Related]
25. Hepatobiliary phase enhancement of liver metastases on gadoxetic acid MRI: assessment of frequency and patterns.
Bhayana R; Baliyan V; Kordbacheh H; Kambadakone A
Eur Radiol; 2021 Mar; 31(3):1359-1366. PubMed ID: 32886204
[TBL] [Abstract][Full Text] [Related]
26. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D
J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
[TBL] [Abstract][Full Text] [Related]
27. Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia.
Vanhooymissen IJSML; Thomeer MG; Braun LMM; Gest B; van Koeverden S; Willemssen FE; Hunink M; De Man RA; Ijzermans JN; Dwarkasing RS
J Magn Reson Imaging; 2019 Mar; 49(3):700-710. PubMed ID: 30252977
[TBL] [Abstract][Full Text] [Related]
28. The role of diffusion-weighted imaging in the detection of hepatic metastases from colorectal cancer: A comparison with unenhanced and Gd-EOB-DTPA enhanced MRI.
Colagrande S; Castellani A; Nardi C; Lorini C; Calistri L; Filippone A
Eur J Radiol; 2016 May; 85(5):1027-34. PubMed ID: 27130067
[TBL] [Abstract][Full Text] [Related]
29. Value of gadoxetic acid-enhanced and diffusion-weighted MR imaging in evaluation of hepatocellular carcinomas with atypical enhancement pattern on contrast-enhanced multiphasic MDCT in patients with chronic liver disease.
Kim HS; Kim SH; Kang TW; Song KD; Choi D; Park CK
Eur J Radiol; 2015 Apr; 84(4):555-62. PubMed ID: 25617950
[TBL] [Abstract][Full Text] [Related]
30. Infiltrative hepatocellular carcinoma on gadoxetic acid-enhanced and diffusion-weighted MRI at 3.0T.
Lim S; Kim YK; Park HJ; Lee WJ; Choi D; Park MJ
J Magn Reson Imaging; 2014 May; 39(5):1238-45. PubMed ID: 24136725
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≤ 1.5 cm in diameter).
Kim YK; Lee MW; Lee WJ; Kim SH; Rhim H; Lim JH; Choi D; Kim YS; Jang KM; Lee SJ; Lim HK
Invest Radiol; 2012 Mar; 47(3):159-66. PubMed ID: 22330426
[TBL] [Abstract][Full Text] [Related]
32. Imaging features of fibrolamellar hepatocellular carcinoma in gadoxetic acid-enhanced MRI.
Palm V; Sheng R; Mayer P; Weiss KH; Springfeld C; Mehrabi A; Longerich T; Berger AK; Kauczor HU; Weber TF
Cancer Imaging; 2018 Mar; 18(1):9. PubMed ID: 29490696
[TBL] [Abstract][Full Text] [Related]
33. Clinical Performance of Abbreviated Liver MRI for the Follow-Up of Patients With Colorectal Liver Metastases.
Torkzad MR; Riddell AM; Chau I; Cunningham D; Koh DM
AJR Am J Roentgenol; 2021 Mar; 216(3):669-676. PubMed ID: 33502225
[No Abstract] [Full Text] [Related]
34. The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA "uptake" on the hepatobiliary phase of MR imaging.
Granata V; Catalano O; Fusco R; Tatangelo F; Rega D; Nasti G; Avallone A; Piccirillo M; Izzo F; Petrillo A
Abdom Imaging; 2015 Oct; 40(7):2364-71. PubMed ID: 26105523
[TBL] [Abstract][Full Text] [Related]
35. MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent gadoxetic acid.
Lee KH; Lee JM; Park JH; Kim JH; Park HS; Yu MH; Yoon JH; Han JK; Choi BI
Korean J Radiol; 2013; 14(6):894-904. PubMed ID: 24265564
[TBL] [Abstract][Full Text] [Related]
36. Staging of colorectal liver metastases after preoperative chemotherapy. Diffusion-weighted imaging in combination with Gd-EOB-DTPA MRI sequences increases sensitivity and diagnostic accuracy.
Macera A; Lario C; Petracchini M; Gallo T; Regge D; Floriani I; Ribero D; Capussotti L; Cirillo S
Eur Radiol; 2013 Mar; 23(3):739-47. PubMed ID: 22976920
[TBL] [Abstract][Full Text] [Related]
37. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
38. Gadoxetic acid-enhanced 3.0T MRI for the evaluation of hepatic metastasis from colorectal cancer: metastasis is not always seen as a "defect" on the hepatobiliary phase.
Kim A; Lee CH; Kim BH; Lee J; Choi JW; Park YS; Kim KA; Park CM
Eur J Radiol; 2012 Dec; 81(12):3998-4004. PubMed ID: 22921889
[TBL] [Abstract][Full Text] [Related]
39. Feasibility of Routine Application of Gadoxetic Acid-Enhanced MRI in Combination with Diffusion-Weighted MRI for the Preoperative Evaluation of Colorectal Liver Metastases.
Tanaka M; Kishi Y; Esaki M; Nara S; Miyake M; Hiraoka N; Nagino M; Shimada K
Ann Surg Oncol; 2016 Nov; 23(12):3991-3998. PubMed ID: 27357179
[TBL] [Abstract][Full Text] [Related]
40. Characterization of small (≤3 cm) hepatic lesions with atypical enhancement feature and hypointensity in hepatobiliary phase of gadoxetic acid-enhanced MRI in cirrhosis: A STARD-compliant article.
Shin SK; Kim YS; Choi SJ; Shim YS; Jung DH; Kwon OS; Choi DJ; Kim JH
Medicine (Baltimore); 2017 Jul; 96(29):e7278. PubMed ID: 28723741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]